Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

NCT04299191 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

High-grade Glioma
Solid Tumor, Unspecified, Child

Interventions

DRUG: LAM561

Sponsor

Laminar Pharmaceuticals

Collaborators

[object Object]
[object Object]
[object Object]